| Period Ended | 12/31/12 | 12/31/11 | 12/31/10 | 12/31/09 | 12/31/08 |
| | Update | Update | Update | Update | Update |
| | 03/28/13 | 04/08/13 | 04/08/13 | 04/08/13 | 04/08/13 |
In millions of USD
(except for per share items) |
| Net Sales | 2.71 | 2.44 | 3.56 | 1.73 | 2.80 |
| Revenue | 2.71 | 2.44 | 3.56 | 1.73 | 2.80 |
|
| Total Revenue | 2.71 | 2.44 | 3.56 | 1.73 | 2.80 |
 |
|
| Gross Profit | 2.71 | 2.44 | 3.56 | 1.73 | 2.80 |
|
| Selling / General / Administrative Expense | 20.40 | 23.79 | 18.04 | 14.34 | 16.18 |
| Selling / General / Administrative Expenses, Total | 20.40 | 23.79 | 18.04 | 14.34 | 16.18 |
| Research & Development | 51.37 | 69.32 | 61.69 | 57.62 | 53.66 |
| Purchased R&D Written-Off | .00 | .00 | 35.00 | .00 | -- |
| Restructuring Charge | 2.70 | 5.45 | .00 | .00 | .00 |
| Other Unusual Expense (Income) | .00 | 1.66 | .00 | .00 | .00 |
| Unusual Expense (Income) | 2.70 | 7.11 | 35.00 | .00 | .00 |
|
| Total Operating Expense | 74.47 | 100.22 | 114.73 | 71.96 | 69.85 |
|
|
| Operating Income | -71.76 | -97.78 | -111.17 | -70.23 | -67.04 |
|
| Interest Expense - Non-Operating | -- | -.09 | -- | -- | -- |
| Interest Expense, Net Non-Operating | -- | -.09 | -- | -- | -- |
| Interest Income - Non-Operating | 3.10 | 1.02 | 2.05 | 1.37 | 5.54 |
| Investment Income - Non-Operating | .01 | .14 | -2.16 | -1.37 | -.43 |
| Interest / Investment Income, Non-Operating | 3.11 | 1.16 | -.11 | .00 | 5.12 |
| Interest Income (Expense), Net-Non-Operating, Total | 3.11 | 1.08 | -.11 | .00 | 5.12 |
| Other Non-Operating Income (Expense) | -.23 | -.15 | -.10 | -.14 | -.09 |
| Other, Net | -.23 | -.15 | -.10 | -.14 | -.09 |
|
| Net Income Before Taxes | -68.88 | -96.85 | -111.38 | -70.37 | -62.02 |
|
| Provision for Income Taxes | .00 | .00 | .00 | .00 | .00 |
|
| Net Income After Taxes | -68.88 | -96.85 | -111.38 | -70.37 | -62.02 |
|
|
| Net Income Before Extraordinary Items | -68.88 | -96.85 | -111.38 | -70.37 | -62.02 |
|
|
| Net Income | -68.88 | -96.85 | -111.38 | -70.37 | -62.02 |
|
|
| Income Available to Common Excluding Extraordinary Items | -68.88 | -96.85 | -111.38 | -70.37 | -62.02 |
|
|
| Income Available to Common Stocks Including Extraordinary Items | -68.88 | -96.85 | -111.38 | -70.37 | -62.02 |
|
| Basic Weighted Average Shares | 126.94 | 124.51 | 97.60 | 88.08 | 78.19 |
| Basic EPS Excluding Extraordinary Items | -.54 | -.78 | -1.14 | -.80 | -.79 |
| Basic EPS Including Extraordinary Items | -.54 | -.78 | -1.14 | -.80 | -.79 |
| Dilution Adjustment | .00 | .00 | .00 | .00 | .00 |
|
| Diluted Net Income | -68.88 | -96.85 | -111.38 | -70.37 | -62.02 |
|
| Diluted Weighted Average Shares | 126.94 | 124.51 | 97.60 | 88.08 | 78.19 |
| Diluted EPS Excluding Extraordinary Items | -.54 | -.78 | -1.14 | -.80 | -.79 |
| Diluted EPS Including Extraordinary Items | -.54 | -.78 | -1.14 | -.80 | -.79 |
| DPS - Common Stock Primary Issue | .00 | .00 | .00 | .00 | .00 |
| Gross Dividends - Common Stock | .00 | .00 | .00 | .00 | .00 |
| Stock-Based Compensation, Supplemental | 5.31 | 15.25 | 13.72 | 10.58 | 11.49 |
| Interest Expense, Supplemental | -- | .09 | -- | -- | -- |
| Depreciation, Supplemental | .83 | 1.58 | 1.61 | 1.75 | 2.02 |
| Impairment-Assets Held for Use, Supplemental | -- | -- | -- | .00 | .04 |
| Non-Recurring Items, Total | -- | -- | -- | .00 | .04 |
| Total Special Items | 2.70 | 7.11 | 35.00 | .00 | .04 |
|
| Normalized Income Before Taxes | -66.18 | -89.74 | -76.38 | -70.37 | -61.98 |
|
| Effect of Special Items on Income Taxes | .00 | .00 | .00 | .00 | .00 |
| Income Taxes Excluding Impact of Special Items | .00 | .00 | .00 | .00 | .00 |
|
| Normalized Income After Taxes | -66.18 | -89.74 | -76.38 | -70.37 | -61.98 |
|
|
| Normalized Income Available to Common | -66.18 | -89.74 | -76.38 | -70.37 | -61.98 |
|
| Basic Normalized EPS | -.52 | -.72 | -.78 | -.80 | -.79 |
| Diluted Normalized EPS | -.52 | -.72 | -.78 | -.80 | -.79 |
| Amortization of Intangibles, Supplemental | -- | -- | -- | -- | .00 |
| Rental Expense, Supplemental | 1.47 | 1.31 | 1.32 | 1.32 | 1.26 |
| Equity in Affiliates, Supplemental | .00 | -.50 | -2.35 | -1.34 | -.84 |
| Research & Development Expense, Supplemental | 51.37 | 69.32 | 61.69 | 57.62 | 53.66 |
| Audit Fees | -- | .49 | .65 | .68 | .59 |
| Audit-Related Fees | -- | -- | .00 | .00 | .00 |
| Tax Fees | -- | .01 | .03 | .02 | .01 |
| All Other Fees | -- | .00 | .00 | .00 | .00 |
| Gross Margin | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 |
| Operating Margin | -2,648.87 | -4,010.66 | -3,120.04 | -4,069.18 | -2,391.87 |
| Pretax Margin | -2,542.67 | -3,972.64 | -3,125.93 | -4,077.29 | -2,212.67 |
| Net Profit Margin | -2,542.67 | -3,972.64 | -3,125.93 | -4,077.29 | -2,212.67 |
| Normalized EBIT | -69.06 | -90.67 | -76.17 | -70.23 | -67.00 |
| Normalized EBITDA | -68.23 | -89.09 | -74.56 | -68.48 | -64.98 |
RSS Feeds | 
E-mail Alerts | 
Financial Tear Sheet